Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Empagliflozin (drug)
• Liraglutide (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Department of Clinical Epidemiology - Aarhus Unversiteteshospital
  Aarhus, Denmark
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• liraglutide (drug) — also listed as: NNC 90-1170
• placebo (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Novo Nordisk Investigational Site
  Bad Lauterberg im Harz, Germany
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• GLP-1 receptor agonist (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Azienda Ospedaliero-Universitaria Policlinico Bari
  Bari, Italy
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Dapagliflozin (drug) — also listed as: Farxiga
• Insulin (drug) — also listed as: Lantus, Levemir, Toujjeo, Humalog , Novolog, Apidra
• Liraglutide (drug) — also listed as: Victoza
• Dapagliflozin placebo (drug) — also listed as: Placebo

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• ECMC Ambulatory Center, 3rd Floor
  Buffalo, New York, United States
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Saxenda (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Seoul National University Hospital
  Seoul, Jongno-gu, South Korea
  Site recruitment: Recruiting

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Liraglutide 1.8mg (drug)
• Placebo (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Diabetes-Endocrinology Center of WNY
  Buffalo, New York, United States
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Liraglutide injection (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Departamento de Cirugia Bariatrica y Metabolica del Hsopital Civil Dr. Juan I. Menchaca
  Guadalajara, Jalisco, Mexico
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Liraglutide (drug) — also listed as: Victoza
• Placebo (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Diabetes-Endocrinology Center of Western NY
  Williamsville, New York, United States
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• liraglutide (drug)
• liraglutide (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Novo Nordisk Investigational Site
  Neu-Ulm, Germany
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Liraglutide (Saxenda) 6Mg/Ml Inj Pen 3Ml (drug)
• Continuous positive airway pressure treatment (device)
• Liraglutide and CPAP (combination_product)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• St Vincent's University Hospital
  Dublin, Dublin 4, Ireland
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Insulin Degludec / Liraglutide Injectable Product (drug) — also listed as: Insulin Degludec/Liraglutide
• Insulin Glargine (drug) — also listed as: glargine

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Internal Medicine Ward, University of Palermo
  Palermo, Italy
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Liraglutide 6 MG/ML [Victoza] (drug)
• Placebos (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Turku University Hospital
  Turku, Finland
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Saxenda® (drug) — also listed as: Liraglutide 3.0
• Placebo (other)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Texas Tech Neuroimaging Institute
  Lubbock, Texas, United States
  Site recruitment: Not reported
• Nutrition & Metabolic Health Initiative
  Lubbock, Texas, United States
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Metformin-GLP-1 Receptor Agonist (drug) — also listed as: Metformin-exenatide/liraglutide Therapy
• Metformin-Oral Contraceptive(OC) (drug) — also listed as: Metformin, Diane 35

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• The Second Affiliated Hospital, Third Military Medical University
  Chongqing, Chongqing Municipality, China
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• liraglutide (drug) — also listed as: NNC 90-1170
• placebo (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Novo Nordisk Investigational Site
  Manchester, United Kingdom
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• liraglutide (drug) — also listed as: NNC 90-1170
• placebo (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Novo Nordisk Investigational Site
  Frederiksberg C, Denmark
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• IDegLira (drug) — also listed as: insulin degludec / liraglutide
• insulin degludec (drug)
• Metformin (drug)
• Lifestyle Therapy (behavioral) — also listed as: diet and exercise

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• University of Calgary
  Calgary, Alberta, Canada
  Site recruitment: Not reported
• University of Alberta
  Edmonton, Alberta, Canada
  Site recruitment: Not reported
• Nova Scotia Health Authority
  Halifax, Nova Scotia, Canada
  Site recruitment: Not reported
• McMaster University
  Hamilton, Ontario, Canada
  Site recruitment: Not reported
• St. Joseph's Hospital
  London, Ontario, Canada
  Site recruitment: Not reported
• Western University
  London, Ontario, Canada
  Site recruitment: Not reported
• LMC Manna Research
  Oakville, Ontario, Canada
  Site recruitment: Not reported
• The Ottawa Hospital
  Ottawa, Ontario, Canada
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Liraglutide + Metformin (drug) — also listed as: LIME
• Metformin (drug) — also listed as: MET

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

The registry does not list facilities in this record. This does not mean the study has no sites.

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Liraglutide (drug) — also listed as: Saxenda
• Placebo (drug)
• Smoking Cessation Counseling (behavioral)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Center for Interdisciplinary Research on Nicotine Addiction, University of Pennsylvania
  Philadelphia, Pennsylvania, United States
  Site recruitment: Not reported